Physician profile
Roozbeh Mansour
NPI 1063745388
$23,789.30
in general payments reported to CMS, 2019-2025
21 companies · $3,182 in 2025
The $3,182 reported for 2025 was more than what 86% of Surgery providers received nationally (typical 2025 total: $281).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $127 · 2020: $4,173 · 2021: $8,396 · 2022: $810 · 2023: $4,620 · 2024: $2,482 · 2025: $3,182.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $9,144 · Travel and Lodging: $1,140.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $9,143.60 |
| Travel and Lodging | $1,140.12 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $12,698.55 | 2020-2025 | Da Vinci Surgical System |
| Kerecis Limited | $6,676.83 | 2022-2025 | Kerecis Omega3 Surgiclose, Kerecis Omega3 Marigen, Kerecis Omega3 Graftguide |
| Access Pro Medical, LLC | $1,560.33 | 2025 | Matriderm |
| Integra Lifesciences Corporation | $609.84 | 2022-2023 | Integra, Primatrix, Integra Dermal Regeneration Template |
| Biotissue Holdings INC. | $366.24 | 2025 | |
| Polynovo North America LLC | $312.85 | 2022-2025 | Novosorb Btm |
| Acera Surgical, INC. | $289.01 | 2025 | Restrata Wound Matrix |
| Tela Bio, INC. | $288.09 | 2024-2025 | Ovitex 2s, Ovitex Reinforced Bioscaffold With Permanent Polymer (Ovitex) |
| Ethicon US, LLC | $191.41 | 2020-2025 | Echelon Endopath, Enseal X1, Echelon Circular |
| Conmed Corporation | $162.85 | 2025 | Conmed Specimen Retrieval, Conmed Trocars, Airseal |
| Aroa Biosurgery Incorporated | $149.90 | 2024 | |
| Depuy Synthes Sales INC. | $143.92 | 2023 | Matrixrib |
| Acell, INC. | $99.73 | 2019 | |
| Bioventus LLC | $66.94 | 2022 | |
| Avita Medical Americas, LLC | $43.87 | 2024 |
Show all 21 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Allergan, INC. | $27.04 | 2019 | |
| Medtronic, INC. | $26.50 | 2021 | |
| Janssen Biotech, INC. | $25.71 | 2023 | Tremfya |
| Btg International INC. | $21.42 | 2025 | Aurlumyn |
| Zimmer Biomet Holdings, INC. | $15.25 | 2021 | |
| Davol INC. | $13.02 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Roozbeh Mansour listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.